Category: NewsThe default category.
The default category.

Evaluating the value of supportive medical apps during the treatment for breast cancer
Young-Afat et al, 2014; Amsterdam EBCC9.

First place in the Digital Health Masterclass Challenge 2013
Px HealthCare won first place in the Digital Health Masterclass Challenge held by Janssen Healthcare Innovation and Johnson & Johnson Innovation.
Home
Our mission is to revolutionise the use of the patient’s voice to improve both patient experience and clinical outcomes in cancer.

NHS Innovation Accelerator
Anne joined the NHS Innovation Accelerator (NIA) from the Netherlands … Continue reading “NHS Innovation Accelerator”

Optimising oncology outcomes with a mobile app for breast cancer patients: A qualitative evaluation.
2016 NCRI Conference

Is there value in using patient recorded outcome measures to improve toxicity management patients receiving chemotherapy for breast cancer?
2017 Annual British Oncology Pharmacy Association Symposium
Extended: Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App
Find here the extended notes associated with the RELATE-2 Study, Owise and Px Healthcare.

Px HealthCare Presents Comparative Regional Evaluation of OWise Breast Cancer Patient Support App
Px HealthCare, the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence study at the San Antonio Breast Cancer Symposium 2023.

Px HealthCare Unveils First-of-its-Kind, Real World Evidence Study Using OWise Breast Cancer Patient Support App
Px HealthCare, the digital health company behind the clinically-validated OWise cancer patient support app, announced today the presentation of a first-of-its-kind Real World Evidence study at the San Antonio Breast Cancer Symposium 2023.

OWise receives top prize in Scotland’s Cancer Innovation Challenge
OWise was one of the projects selected to win the finals and progress to phase two of the Cancer Innovation Challenge!